Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02760160 · ClinicalTrials.gov registry record · NA

Dietary Prevention of Photodamage in Skin With Grapes

A NA study of Non-Melanoma Skin Cancer, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02760160: Completed NA study of Non-Melanoma Skin Cancer, sponsored by University of Alabama at Birmingham.

NCT02760160 is a NA study of Non-Melanoma Skin Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 18 participants, below the 105-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02760160, a NA study of Non-Melanoma Skin Cancer, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

To assess the effect of orally administered grape powder on the sunburn reaction in humans.

Primary Outcome

Assessment will be quantified by evaluation of a person's minimal erythema dose (MED), the smallest amount of ultraviolet (UV) required to achieve a sunburn response. 6 small areas of skin (2 inches by 2 inches) on the inner part of a person's arm will be exposed to 6 separate but increasing doses of UV. 24 hours after UV treatment, the area that received the smallest dose of UV and has a visible area of redness will be marked and the respective UV dose will be considered the MED. A desirable ou

Conditions Studied

Interventions

  • OTHER Reconstituted grape powder

Study Locations (1)

Alabama

  • UAB Dermatology - Birmingham

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-10
Est. Completion 2018-09-27
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02760160 record still lists

NCT02760160 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 105-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Reconstituted grape powder is the first listed.

NCT02760160 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT02760160 about?

NCT02760160 is a clinical study titled "Dietary Prevention of Photodamage in Skin With Grapes". To assess the effect of orally administered grape powder on the sunburn reaction in humans.

What is the current status of trial NCT02760160?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-10. Estimated completion is 2018-09-27.

What conditions does trial NCT02760160 study?

This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.

What interventions are being tested in trial NCT02760160?

The interventions under investigation include: Reconstituted grape powder (OTHER).

Who is sponsoring clinical trial NCT02760160?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02760160 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Melanoma Skin Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02760160, the US trial registry maintained by the National Library of Medicine. NCT02760160 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.